This table is published annually in the December issue. Its purpose is to provide the reader of Neuromuscular Disorders with an updated list of monogenic muscle diseases due to a primary defect residing in the nuclear genome. It comprises diseases in which the causative gene is known or at least localized on a chromosome, if not yet identified. Diseases for which the locus has not been mapped or which are due to defects involving mitochondrial genes are not included. 1 As in past years the diseases are classified into 16 groups:
General features
This table is published annually in the December issue. Its purpose is to provide the reader of Neuromuscular Disorders with an updated list of monogenic muscle diseases due to a primary defect residing in the nuclear genome. It comprises diseases in which the causative gene is known or at least localized on a chromosome, if not yet identified. Diseases for which the locus has not been mapped or which are due to defects involving mitochondrial genes are not included. 1 As in past years the diseases are classified into 16 groups: In each group every entry corresponds to a clinical entity and has an item number. 2 A given gene may be involved in several different clinical entities (phenotypic heterogeneity such as in LMNA defects) and conversely a given clinical entity may be produced by a defect in several possible alternative genes (genotypic heterogeneity such as in CMT). In some diseases both kinds of heterogeneity may occur. As a consequence a gene or a disease may be cited in several places of the table.
The two versions of the gene table 3
The annual printed version below is abridged and does not contain the Arrhythmogenic Hereditary Cardiomyopathies (Group 10-B), Hereditary Ataxias (Group 13) , and Hereditary Paraplegias (Group 15) . The list of references is restricted to new key references corresponding to the items added or implemented since the preceding year.
The full online version contains the complete data of the 16 groups and the cumulative list of key references since 1991. It is freely accessible at http://www.musclegenetable.fr. It is designed to cope with the complexity described above. In this version the data are cross-referenced and linked to PubMed and to major databases related to molecular medicine (Leiden Muscular Dystrophy, OMIM, NCBI, Genatlas, Orphanet, GeneCards) . It contains several query tools allowing one to perform a variety of interrogations. This computerized version of the table is now surpassing the printed version which cannot accommodate the ever increasing volume and complexity of data. The statistics tool instantly provides the latest list of genes, proteins, phenotypes and cumulative bibliographic key references. Each list can be displayed, printed and exported in Excel format.
Overview of the new data in the 2018 printed version of the gene table
There are 35 new items, marked by background shading. Altogether they comprise 28 additional genes and 8 additional phenotypic variants caused by a gene already listed in the 2017 version (see box).
New in the 2017 printed version of the gene (1987, 1988) Hoffman et al. (1987, 1988) Allelic to CMD3B (group 10)
Emery-Dreifuss muscular dystrophy, X-linked, type 1 Wijmenga et al. (1990, 1991, 1992, 1993) Upadhyaya et al. (1990, 1992) Wright et al. (1993) (1996 ( ) Nigro et al. (1996 Allelic to CMD1L (group 10)
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10-B FOR ARRHYTHMOGENIC CARDIOMYOPATHIES AND RELATED SYNDROMES See online version of the gene
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